Evidence map›Paper›PMID 36063758›Full record

ArticleNeuroImage. Clinical2022

Elveda Gozdas, Lauren Hinkley, Hannah Fingerhut, Lauren Dacorro, Meng Gu, Matthew D Sacchet, Ralph Hurd, S M Hadi Hosseini

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in NeuroImage. Clinical, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Elveda GozdasDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: elvedags@stanford.edu.
Lauren HinkleyDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Hannah FingerhutDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Lauren DacorroDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Meng GuDepartment of Radiology, Stanford University, Stanford, CA, USA.
Matthew D SacchetCenter for Depression, Anxiety, and Stress Research, McLean Hospital, Harvard Medical School, Belmont, MA, USA.
Ralph HurdDepartment of Radiology, Stanford University, Stanford, CA, USA.
S M Hadi HosseiniDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Stanford University · USHarvard University · US

Funding

Microstructural changes in gray and white matter in aging and ADR01AG073362 · NIA · STANFORD UNIVERSITY · PI Hadi Hosseini · 2022 to 2026
$3.7M
Interactive Effects of Aging and AD on Brain NetworksR01AG072470 · NIA · STANFORD UNIVERSITY · PI Hadi Hosseini · 2022 to 2026
$2.9M
A Novel Neuromonitoring Guided Cognitive Intervention for Targeted Enhancement of Working MemoryR61MH119289 · NIMH · STANFORD UNIVERSITY · PI HOSSEINI, HADI · 2019 to 2021
$787k
The influence of multi-domain cognitive training on large-scale structural and functional brain networks in MCIK25AG050759 · NIA · STANFORD UNIVERSITY · PI HOSSEINI, HADI · 2016 to 2020
$739k
A Wearable Optical Imaging System for Daily Monitoring of Prefrontal Activity in ADHDR21MH123873 · NIMH · STANFORD UNIVERSITY · PI BOWDEN, AUDREY KYNSELLA, HOSSEINI, HADI · 2020 to 2020
$443k
Development of a cost-effective and neurobiologically valid VR assessment tool for early detection of ADR21AG073973 · NIA · STANFORD UNIVERSITY · PI HOSSEINI, HADI · 2021 to 2022
$433k
Multi-dimensional network framework for AD detection and progressionR21AG064263 · NIA · STANFORD UNIVERSITY · PI HOSSEINI, HADI · 2019 to 2020
$430k
NIA NIH HHS K25 AG050759NIA NIH HHS R01 AG072470NIA NIH HHS R01 AG073362NIA NIH HHS R21 AG064263NIA NIH HHS R21 AG073973NIMH NIH HHS R21 MH123873NIMH NIH HHS R61 MH119289
6 · The paper itself

Abstract

Alzheimer's disease (AD) pathogenesis is associated with alterations in neurometabolites and cortical microstructure. However, our understanding of alterations in neurochemicals in the prefrontal cortex and their relationship with changes in cortical microstructure in AD remains unclear. Here, we studied the levels of neurometabolites in the left dorsolateral prefrontal cortex (DLPFC) in healthy older adults and patients with amnestic Mild Cognitive Impairments (aMCI) using single-voxel proton-magnetic resonance spectroscopy (

Indexed as

Alzheimer DiseaseCognitive DysfunctionAgedAspartic AcidCognitionCreatineGlutamic AcidHumansInositolProton Magnetic Resonance SpectroscopyAspartic AcidCreatineGlutamic AcidInositolAlzheimer’s diseaseDorsolateral prefrontal cortexMagnetic resonance spectroscopyNeurite microstructures

Identifiers

PMID36063758
PMCPMC9450331
OpenAlexW4292559926

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.